INV-321

N/A

Report date: 2023/11/01 09:27:02

Base Information

Drug NameINV-321

Drug Alias NameINV-321

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitorsInterleukin-2 receptor alpha chain inhibitors

TargetsCytotoxic T-Lymphocyte-Associated Antigen 4Interleukin-2 receptor alpha chain

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesInvenra Inc

China Registration ClassN/A

Develop Information

Active CompaniesInvenra Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A